Health
The Longevity Marketplace, Decoded: What They’re Selling, and What the Evidence Says
Senolytics, NAD, NMN, and five-figure clinics. A seven-part guide to the longevity market: who is talking, what they are selling,…
Section
Wellness
7 stories
Health
The Longevity Marketplace, Decoded: What They’re Selling, and What the Evidence Says
Senolytics, NAD, NMN, and five-figure clinics. A seven-part guide to the longevity market: who is talking, what they are selling,…
Health
Decode Your Wellbeing: The Full Guide to the Longevity Boom, in Eight Parts
Age reversal, biological-age tests, senolytics, and the habits that actually hold up. A clear-eyed guide to the longevity boom, one…
Health
Whoop Opened a $799 Cancer Blood Test to Everyone. Here Is What the Numbers Actually Show.
Whoop just made a $799 cancer blood test available to anyone, no membership required. The technology is real. So are…
Health
Autofocus Glasses Are Coming: How Close Are We to Replacing Fixed Prescriptions?
Glasses that refocus as your eyes do, in a frame that looks ordinary. How close IXI and ViXion actually are…
Health
New Dental Tools: Longer-Lasting Care or a More Expensive Tool Belt?
Implants are a real advance. Same-day crowns and lasers often change the experience and the bill more than they change…
Health
Nervous System Care Is the New Daily Essential
The industry calls it neurowellness and it is the biggest wellness story of the year. Some of it holds up…
Health
Insurers Say They ‘Can’t Afford’ Ozempic and Zepbound. What the Data on Healthier Patients and Cost Savings Actually Shows.
Insurers say the new weight-loss drugs are unaffordable. The data on healthier patients tells a more complicated story.